Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia

Lu Z, Liu Y, Jiang Z, Zhu Y, Liu W, Sun Q, Fan L, Qian S, Hong M

Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:621412

Published Date: 15 July 2026